NUTEX Investments (BUD:NUTEX) YoY EBITDA Growth: 108.34% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUD:NUTEX NUTEX Investments PLC BUD:NUTEX
19 GF Score
Price Ft12.55
! 3 Warning Signs
View Full Analysis

What is NUTEX Investments YoY EBITDA Growth?

NUTEX Investments BUD:NUTEX 19 YoY EBITDA Growth is 108.34% as of Dec. 2025. GuruFocus rates BUD:NUTEX with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. NUTEX Investments's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 108.34%.

NUTEX Investments's EBITDA per Share for the six months ended in Dec. 2025 was Ft3.17.

NUTEX Investments YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for NUTEX Investments's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NUTEX Investments YoY EBITDA Growth Chart

NUTEX Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.07 510.13 22.51 136.83 83.13

NUTEX Investments Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.49 1,183.54 13.32 -43.61 108.34
BUD:NUTEX
19GF Score
NUTEX Investments PLC BUD:NUTEX
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NUTEX Investments YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

NUTEX Investments's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(5.122-2.797)/ | 2.797 |
=83.12 %

NUTEX Investments's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(3.173-1.523)/ | 1.523 |
=108.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 108.34% mean?
NUTEX Investments (BUD:NUTEX) has a YoY EBITDA Growth of 108.34% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for NUTEX Investments and its competitors.
Is NUTEX Investments' YoY EBITDA Growth too high?
NUTEX Investments' current YoY EBITDA Growth is 108.34%. Overall, NUTEX Investments has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does NUTEX Investments' YoY EBITDA Growth compare to ZTS and UTHR?
NUTEX Investments' YoY EBITDA Growth of 108.34% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for NUTEX Investments and its competitors. NUTEX Investments's current YoY EBITDA Growth is 108.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NUTEX Investments stock overvalued right now?
NUTEX Investments (BUD:NUTEX) has a current YoY EBITDA Growth of 108.34%. The current YoY EBITDA Growth is 108.34%. NUTEX Investments' overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current YoY EBITDA Growth is 108.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NUTEX Investments Business Description

Address Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
19GF Score

Get the complete analysis for BUD:NUTEX

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft12.55
Price